Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression

Adachi, 1986, Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone, J. Virol., 59, 284, 10.1128/JVI.59.2.284-291.1986

Akari, 2001, The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors, J. Exp. Med., 194, 1299, 10.1084/jem.194.9.1299

Bour, 1996, The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses, J. Virol., 70, 8285, 10.1128/JVI.70.12.8285-8300.1996

Bour, 2000, HIV accessory proteins: multifunctional components of a complex system, Adv. Pharmacol., 48, 75, 10.1016/S1054-3589(00)48004-X

Bour, 1996, The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?, J. Virol., 70, 820, 10.1128/JVI.70.2.820-829.1996

Bour, 1999, Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity, J. Virol., 73, 778, 10.1128/JVI.73.1.778-782.1999

Bour, 2001, The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B, J. Biol. Chem., 276, 15920, 10.1074/jbc.M010533200

Bour, 2003, Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release, Virology, 309, 85, 10.1016/S0042-6822(02)00128-9

Chang, 1989, Regulation by HIV Rev depends upon recognition of splice sites, Cell, 59, 789, 10.1016/0092-8674(89)90602-8

Gottlinger, 1993, Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses, Proc. Natl. Acad. Sci. U.S.A., 90, 7381, 10.1073/pnas.90.15.7381

Graf, 2000, Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression, J. Virol., 74, 10822, 10.1128/JVI.74.22.10822-10826.2000

Greenberg, 1984, Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene, Nature, 311, 433, 10.1038/311433a0

Haas, 1996, Codon usage limitation in the expression of HIV-1 envelope glycoprotein, Curr. Biol., 6, 315, 10.1016/S0960-9822(02)00482-7

Hirt, 1967, Selective extraction of polyoma DNA from infected mouse cell cultures, J. Mol. Biol., 26, 365, 10.1016/0022-2836(67)90307-5

Hollams, 2002, mRNA stability and the control of gene expression: implications for human disease, Neurochem. Res., 27, 957, 10.1023/A:1020992418511

Humphreys, 2000, High-level periplasmic expression in Escherichia coli using a eukaryotic signal peptide: importance of codon usage at the 5′ end of the coding sequence, Protein Expr. Purif., 20, 252, 10.1006/prep.2000.1286

Jeang, 1999, Multifaceted activities of the HIV-1 transactivator of transcription, Tat, J. Biol. Chem., 274, 28837, 10.1074/jbc.274.41.28837

Kim, 1993, TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein, J. Virol., 67, 239, 10.1128/JVI.67.1.239-248.1993

Kim, 1997, Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells, Gene, 199, 293, 10.1016/S0378-1119(97)00384-3

Kimpton, 1992, Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene, J. Virol., 66, 2232, 10.1128/JVI.66.4.2232-2239.1992

Kjems, 2000, Rev protein and its cellular partners, Adv. Pharmacol., 48, 251, 10.1016/S1054-3589(00)48009-9

Klimkait, 1990, The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release, J. Virol., 64, 621, 10.1128/JVI.64.2.621-629.1990

Kobinger, 1997, Enhancement of retroviral production from packaging cell lines expressing the human immunodeficiency type 1 VPU gene, Gene Ther., 4, 868, 10.1038/sj.gt.3300452

Kotsopoulou, 2000, A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag–pol gene, J. Virol., 74, 4839, 10.1128/JVI.74.10.4839-4852.2000

Kozak, 1987, At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells, J. Mol. Biol., 196, 947, 10.1016/0022-2836(87)90418-9

Kypr, 1987, Unusual codon usage of HIV, Nature, 327, 20, 10.1038/327020a0

Llano, 2002, Blockade of human immunodeficiency virus type 1 expression by caveolin-1, J. Virol., 76, 9152, 10.1128/JVI.76.18.9152-9164.2002

Madisen, 1998, The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes, Mol. Cell. Biol., 18, 6281, 10.1128/MCB.18.11.6281

Maldarelli, 1991, Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation, J. Virol., 65, 5732, 10.1128/JVI.65.11.5732-5743.1991

Ritter, 1996, Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain, J. Virol., 70, 2669, 10.1128/JVI.70.4.2669-2673.1996

Schneider, 1997, Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation, J. Virol., 71, 4892, 10.1128/JVI.71.7.4892-4903.1997

Schwartz, 1992, Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein, J. Virol., 66, 150, 10.1128/JVI.66.1.150-159.1992

Schwartz, 1992, Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs, Mol. Cell. Biol., 12, 207, 10.1128/MCB.12.1.207

Srinivasakumar, 1999, A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery, J. Virol., 73, 9589, 10.1128/JVI.73.11.9589-9598.1999

Strebel, 1987, The HIV ‘A’ (sor) gene product is essential for virus infectivity, Nature, 328, 728, 10.1038/328728a0

Strebel, 1988, A novel gene of HIV-1, vpu, and its 16-kilodalton product, Science, 241, 1221, 10.1126/science.3261888

Vervoort, 2000, Optimizing heterologous expression in dictyostelium: importance of 5′ codon adaptation, Nucleic Acids Res., 28, 2069, 10.1093/nar/28.10.2069

Wagner, 2000, Rev-independent expression of synthetic gag–pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors, Hum. Gene Ther., 11, 2403, 10.1089/104303400750038507

Willey, 1988, In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity, J. Virol., 62, 139, 10.1128/JVI.62.1.139-147.1988

Wolff, 1997, Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA, Chem. Biol., 4, 139, 10.1016/S1074-5521(97)90257-X

zur Megede, 2000, Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene, J. Virol., 74, 2628, 10.1128/JVI.74.6.2628-2635.2000